Physician

Rekha Sehgal, M.D.

According to 2025 Medicare claims, Rekha Sehgal, M.D. (NPI: 1629019955) practices family practice in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is EXCELCARE ALLIANCE, LLC (NPI: 1891090510; TIN: 272753377) and primary practice location at 08360-5838.

Sehgal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 553 traditional Medicare patients, billed 4,554 HCPCS/CPT codes, and received $354,860 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 20,678 prescription claims across 1,012 beneficiaries totaling $2,049,854 in drug costs, led by Eliquis (Apixaban). DME data shows 229 claims. Open Payments data shows 52 records totaling $1,064. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $66,702 to $17,664.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	979	6,217	$442,245
2016	975	7,588	$522,107
2017	916	7,400	$510,565
2018	905	6,742	$472,836
2019	720	5,607	$398,495
2020	670	5,220	$358,875
2021	644	5,135	$394,138
2022	662	4,992	$370,713
2023	644	4,673	$362,002
2024	553	4,554	$354,860

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	830	26,875	$1,683,304
2016	861	26,882	$1,746,660
2017	852	22,183	$1,612,561
2018	925	24,730	$1,947,359
2019	889	24,487	$2,088,723
2020	868	22,991	$2,124,865
2021	827	19,616	$1,797,451
2022	868	19,129	$1,954,653
2023	984	20,647	$2,289,129
2024	1,012	20,678	$2,049,854

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	352	1,730	$92,655
2016	305	1,228	$41,618
2017	142	972	$30,407
2018	130	743	$17,679
2019	95	679	$19,238
2020	86	785	$26,360
2021	76	583	$17,847
2022	37	299	$9,679
2023	196	651	$738,467
2024	13	229	$10,461

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	141	263	$135
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	137	152	$107
99239	Hospital discharge day management, more than 30 minutes	147	170	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	124	188	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	245	1,404	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	440	11,835	$221,151
Ozempic	Semaglutide	116	6,122	$192,916
Farxiga	Dapagliflozin Propanediol	301	9,960	$182,901
Xifaxan	Rifaximin	97	1,303	$149,885
Xarelto	Rivaroxaban	124	5,379	$97,693

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$3,897
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$1,962
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	33	$1,367
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	19	$692
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	15	$520

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,064	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rekha Sehgal, M.D.?

Tedicare shows public-source Medicare data for Rekha Sehgal, M.D. (NPI 1629019955), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rekha Sehgal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rekha Sehgal, M.D.?

Rekha Sehgal, M.D. is linked to EXCELCARE ALLIANCE, LLC (billing NPI 1891090510) in the available physician profile data.

Does Rekha Sehgal, M.D. have Open Payments data?

Rekha Sehgal, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.